Category:
Description:
Indications:
Contraindications:
-
Current
or history of thrombophlebitis, thromboembolic disorders, and cerebral
apoplexy
-
Liver
impairment, known or suspected malignancy of the breast or genitalia
-
Undiagnosed
genital bleeding
-
Missed
abortion
-
Use
as a pregnancy diagnostic test
Precautions:
-
Pregnancy
category D (Provera and Cycrin)
-
Pregnancy
category X (Depo Provera)
-
Use
with caution in pregnant or nursing mothers
-
Use
with caution in patients with diabetes, epilepsy, migraine, asthma,
cardiac or renal dysfunction, or history of depression.
-
Injectable
form of contraception has an extended duration of three months.
-
Immediately
discontinue therapy and consult health care provider if pregnancy is
suspected.
Adverse
Reactions (Side Effects):
-
Rash,
alopecia, acne, hirsutism
-
Abnormal
menstrual bleeding, changes in cervical secretions
-
Edema,
weight change
-
Depression,
insomnia, somnolence
-
Nausea
-
Injection
site irritation
|
Dosage:
Administered
orally or injection
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|